» Articles » PMID: 30121983

Neural Signature for Auditory Hallucinations in Schizophrenia: A High-Resolution Positron Emission Tomography Study with Fludeoxyglucose (F)

Overview
Specialty Psychiatry
Date 2018 Aug 21
PMID 30121983
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Auditory hallucinations (AHs) are a core symptom of schizophrenia. We investigated the neural signature of AHs by comparing hallucinating patients with schizophrenia with non-hallucinating patients with schizophrenia.

Methods: We recruited hallucinating patients with schizophrenia meeting the criteria for persistent, prominent, and predominant AHs (n=10) and non-hallucinating patients with schizophrenia (n=12). Various clinical assessments were performed incluing Psychotic Symptom Rating Scale for Auditory Hallucinations. Using fludeoxyglucose (F) positron emission tomography, regional differences in neural activity between the groups were analyzed.

Results: The regions of interest analysis showed significantly lower standardized uptake value ratio (SUVR) in the superior, middle, and inferior frontal gyri, and higher SUVR in the putamen in patients with AHs versus patients without AHs. These findings were confirmed in the voxel-wise analysis.

Conclusion: Our findings indicate that hypoactivity in the frontal and cingulate gyri, coupled with hyperactivity in the temporal gyrus and putamen, may contribute to the pathophysiology of AHs.

Citing Articles

Targeting auditory verbal hallucinations in schizophrenia: effective connectivity changes induced by low-frequency rTMS.

Yuanjun X, Guan M, Zhang T, Ma C, Wang L, Lin X Transl Psychiatry. 2024; 14(1):393.

PMID: 39341819 PMC: 11438995. DOI: 10.1038/s41398-024-03106-4.


Cerebral blood flow changes in schizophrenia patients with auditory verbal hallucinations during low-frequency rTMS treatment.

Xie Y, Guan M, Wang Z, Ma Z, Fang P, Wang H Eur Arch Psychiatry Clin Neurosci. 2023; 273(8):1851-1861.

PMID: 37280358 DOI: 10.1007/s00406-023-01624-8.


Patterns of Impaired Neurocognitive Performance on the Global Neuropsychological Assessment, and Their Brain Structural Correlates in Recent-onset and Chronic Schizophrenia.

Mohan V, Parekh P, Lukose A, Moirangthem S, Saini J, Schretlen D Clin Psychopharmacol Neurosci. 2023; 21(2):340-358.

PMID: 37119227 PMC: 10157005. DOI: 10.9758/cpn.2023.21.2.340.


Numerical density of oligodendrocytes and oligodendrocyte clusters in the anterior putamen in major psychiatric disorders.

Kolomeets N, Uranova N Eur Arch Psychiatry Clin Neurosci. 2020; 270(7):841-850.

PMID: 32060609 DOI: 10.1007/s00406-020-01108-z.

References
1.
Posner M, Dehaene S . Attentional networks. Trends Neurosci. 1994; 17(2):75-9. DOI: 10.1016/0166-2236(94)90078-7. View

2.
Pantelis C, Barnes T . Drug strategies and treatment-resistant schizophrenia. Aust N Z J Psychiatry. 1996; 30(1):20-37. DOI: 10.3109/00048679609076070. View

3.
Barta P, Pearlson G, Powers R, RICHARDS S, Tune L . Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry. 1990; 147(11):1457-62. DOI: 10.1176/ajp.147.11.1457. View

4.
Shergill S, Bullmore E, Simmons A, Murray R, McGuire P . Functional anatomy of auditory verbal imagery in schizophrenic patients with auditory hallucinations. Am J Psychiatry. 2000; 157(10):1691-3. DOI: 10.1176/appi.ajp.157.10.1691. View

5.
Copolov D, Seal M, Maruff P, Ulusoy R, Wong M, Tochon-Danguy H . Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study. Psychiatry Res. 2003; 122(3):139-52. DOI: 10.1016/s0925-4927(02)00121-x. View